CSI Market
Sign In | Register

Verde Bio Holdings Inc (APHD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access APHD Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Verde Bio Holdings Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jan 31 2024)
9 Months 		(Oct 31 2023) (Jul 31 2023) (Apr 30 2023) (Jan 31 2023)
Operating Activities
Income-4.34
Depreciation & amortization0.19
Amortization of Other Assets0.02
Accretion Expense0.00
Impairment of Oil and Gas Properties0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-1.07
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Debt Instrument, Convertible, Beneficial Conversion Feature0.00
Costs And Expenses Related Party-
Gains Losses On Settlement Of Debt-
Interest Expense Other-
Expenses Paid On Behalf Of The Company-
Expenses Paid By Related Party-
Debt Issuance Costs-
Derivative Gain Loss On Derivative Net-
Allowance For Doubtful Accounts Receivable Write Offs-
Original Issue Discount0.02
Finance Lease Right Of Use Asset Amortization0.02
Default And Conversion Fees-
Rent Free Period On Operating Lease-
Increase Decrease In Operating Lease Liability-0.02
Right Of Use Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.02
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.06
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.04
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.94
Investing Activities
Capital Expenditures-0.07
Sale of Capital Items0.55
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.48
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.69
Long-term debt - repayments-0.34
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.10
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.23
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Advances-
Proceeds From Subscriptions Payable-
Proceeds From Issuance Of Ppp Loan Sba-
Proceeds From Common Stock Issuable0.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.45
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.46
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Verde Bio Holdings Inc cash flow history.

Sign In Create Free Account

About Verde Bio Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-24-025549

Figures are derived from filed reports and may be restated. Historical data is subject to revision.